Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
August 2003
Features
Spotlight
Editorial Board Spotlight: Thomas Biancaniello, MD
Sonja Sherritze
FDA Update
Drug Safety Revisions
Dr. Goldenberg presents the latest labeling changes for atorvastatin (Lipitor®), risperidone (Risperdal®), Gynecare Intergel Adhesion Prevention Solution® to heal adhesions after gynecological surgery, and lindane (Kwell®) to treat lice and scabies.
Marvin M. Goldenberg, PhD, RPh, MS
Principles of Antibiotic Formulary Selection for P&T Committees, Part 3: Antibiotic Resistance
Dr. Cunha describes natural and acquired resistance to antimicrobial agents and effective strategies to control this growing problem.
Burke A. Cunha, MD
Highlights of the 39th Annual Meeting of the American Society of Clinical Oncology
Dr. Prescott discusses advances in the treatment of breast, pancreatic, and colorectal cancers; bronchoalveolar cell carcinoma; refractory cancers; melanoma; non-Hodgkin’s lymphoma; leukemia; and chemotherapy-induced anemia.
Lawrence M. Prescott, PhD
Continuing Education Credit
Antiretroviral Therapy in HIV-Infected Adults, Part 1
The authors review the armamentarium of medications used to treat AIDS and HIV infection.
Eli Korner, PharmD, MPH, Mary Ellen Bonk, PharmD, Thomas Ratko, PhD, and Karl Matuszewski, MS, PharmD
Departments
Editorial
Medicare Drug Coverage: LMRP, CAC, and NCD
Editor-in-Chief David Nash, MD, MBA, translates some new acronyms used in drug coverage under Medicare: LMRP, CAC, and NCD.
David B. Nash, MD, MBA
Medication Errors
Measuring Medication Safety: What Works? What Doesn’t?
Matthew Grissinger discusses ways to measure the effectiveness and safety of medication use.
Prescription: Washington
Pharmacy Residency Programs Endangered
Stephen Barlas describes possible changes in Medicare’s reimbursements to hospitals with pharmacist residency programs.
Drug News
New Drugs/Drug News
P&T presents the latest information about approvals, indication changes, industry updates, and news from the FDA.
Drug Forecast
Adalimumab: The First Entirely Human Monoclonal Antibody for Rheumatoid Arthritis
Drs. Mack and Neely review adalimumab (Humira®) for the treatment of rheumatoid arthritis.
Alicia Mack, PharmD, and Jessica Neely, PharmD
P&T Snapshot
The Changing Face of AIDS
